HOMB(HOMB)
HOMB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.16B | $1.20B | $1.24B |
| Low | $1.15B | $1.19B | $1.24B |
| High | $1.17B | $1.23B | $1.25B |
| EBITDA Avg | $516M | $537M | $555M |
| Low | $511M | $533M | $552M |
| High | $520M | $546M | $557M |
| EBIT Avg | $490M | $510M | $527M |
| Low | $486M | $506M | $524M |
| High | $494M | $519M | $529M |
| Net Income Avg | $497M | $514M | $533M |
| Low | $495M | $503M | $524M |
| High | $499M | $524M | $542M |
| EPS Avg | $2.51 | $2.60 | $2.69 |
| Low | $2.50 | $2.55 | $2.65 |
| High | $2.52 | $2.65 | $2.74 |
| Analysts (Rev / EPS) | 4 / 5 | 6 / 6 | 1 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $295M | $295M | $290M | $298M | $304M | $306M |
| Low | $291M | $291M | $286M | $294M | $299M | $301M |
| High | $298M | $298M | $293M | $302M | $307M | $309M |
| EBITDA Avg | $131M | $131M | $129M | $133M | $136M | $137M |
| Low | $130M | $130M | $127M | $131M | $133M | $134M |
| High | $133M | $133M | $131M | $135M | $137M | $138M |
| EBIT Avg | $125M | $125M | $123M | $126M | $129M | $130M |
| Low | $123M | $123M | $121M | $124M | $127M | $128M |
| High | $126M | $126M | $124M | $128M | $130M | $131M |
| Net Income Avg | $126M | $127M | $123M | $127M | $130M | $132M |
| Low | $123M | $125M | $121M | $125M | $128M | $129M |
| High | $128M | $128M | $125M | $129M | $132M | $134M |
| EPS Avg | $0.64 | $0.64 | $0.62 | $0.64 | $0.66 | $0.67 |
| Low | $0.62 | $0.63 | $0.61 | $0.63 | $0.65 | $0.65 |
| High | $0.65 | $0.65 | $0.63 | $0.65 | $0.67 | $0.68 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 4 / 3 | 4 / 3 | 4 / 3 | 4 / 3 |